Web Dentalarticles.com
   Drugs and Chemicals /  T   Tretinoin (Tretinoin Zinc Salt, Vesanoid,)

An important regulator of gene expression during growth and development, and in neoplasms. Tretinoin, also known as retinoic acid and derived from maternal vitamin A, is essential for normal growth and embryonic development. An excess of tretinoin can be teratogenic. It is used in the treatment of psoriasis; acne vulgaris; and several other skin diseases. It has also been approved for use in promyelocytic leukemia.


References:
   Related Diseases   

Leukemia
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. It is classified according to degree of cell differentiation as acute or chronic, and according to predominant type of cell involved as myelogenous or lymphocytic.
[ Articles]



 Pharmacologic Action
  • Keratolytic Agent
    Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.
  • Antineoplastic Agent
    Substances that inhibit or prevent the proliferation of neoplasms.

       Related Diseases   

    Psoriasis
    A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
    [ Articles] [ Images]


Psoriasis News 07 Aug 2008
Yahoo! News Search Results for psoriasis
Yahoo! News Search Results for psoriasis

JCI online early table of contents: August 7, 2008 (EurekAlert!)
New data, generated by Thomas Jung and colleagues, at Novartis Exploratory Development, Switzerland, have indicated that a drug known currently as AEB071 can reduce the clinical symptoms of psoriasis, a chronic, currently incurable autoimmune skin disease.
Unrecognized Potential at Abbott Labs (Washington Post)
Shareholders of Abbott Laboratories have been getting the Chinese water-torture treatment lately, having to contend with a thin but steady trickle of sour news about the big health care company. But Abbott's shares have held up remarkably well, suggesting that the slow drip isn't distracting the...
Many people don't get prescriptions filled (Reuters via Yahoo! News)
One in three people who are prescribed medications may never get them filled, a new study in patients being treated for skin conditions has found.
August is Psoriasis Awareness Month (PR Newswire via Yahoo! News)
Pools are for recreation, not discrimination
XOMA Reports Second Quarter 2008 Financial Results (PrimeNewswire via Yahoo! Finance)
BERKELEY, Calif., Aug. 7, 2008 -- XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, today announced its results for the quarter ended June 30, 2008.
BioCryst Reports Second Quarter 2008 Financial Results and Provides Corporate Update (PR Newswire via Yahoo! Finance)
BioCryst Pharmaceuticals, Inc. today announced financial results for the quarter ended June 30, 2008.
Micromet, Inc. Reports Second Quarter 2008 Financial Results (PR Newswire via Yahoo! Finance)
Micromet, Inc. , a biopharmaceutical company focusing on the development of novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced its financial results for the second quarter and six months ended June 30, 2008.
Salon customers take plunge for fish pedicures (Knoxville News Sentinel)
ALEXANDRIA, Va. - Ready for the latest in spa pampering? Prepare to dunk your tootsies in a tank of water and let tiny carp nibble away.
Unrecognized Potential at Abbott Labs (KiplingerForecasts.com)
The market isn't fully appreciating this health care company's well-diversified product lines and near-term profitability strength.
Manhattan Pharmaceuticals reports encouraging results from psoriasis trial (Pharmaceutical Business Review)
Manhattan Pharmaceuticals has announced top-line results from its Phase IIa clinical study of topical PTH (1-34) for the treatment of psoriasis.

 

Health and Personal Care Shop 07 Aug 2008

List Price:
Amazon.com Price:
Publisher:
Availability:
Amazon.com sales rank:
Average customer rating:
Buy Now

Warning: Invalid argument supplied for foreach() in /usr/www/users/dentalar/drugs/71.php on line 331



Categorization derived from National Library of Medicine.
Disclaimer